Boston Healthcare grows to meet increasing global demand for health
economics and market access support
BOSTON, Oct. 28 /PRNewswire/ -- Boston Healthcare Associates, Inc. today announced the appointment of Adam Barak as Vice President.
Mr. Barak brings 16 years of pricing and reimbursement experience, including the development of global pricing and reimbursement strategies for drugs, medical devices, and diagnostics in a wide range of therapeutic areas including oncology, pulmonary medicine, gastroenterology, cardiovascular medicine, neurology, and critical care.
"Adam's appointment demonstrates Boston Healthcare's continued commitment to expanding the scope and reach of our services," said Joseph Ferrara, President of Boston Healthcare. "His wealth of experience in pricing and reimbursement will strengthen our position internationally, and provide the expertise and leadership we need to serve our clients more effectively worldwide. Adam is a strong addition to the executive management team and an asset to our global strategy."
Mr. Barak joined GlaxoWellcome's International Pricing & Reimbursement division in 1996. In 1997, Mr. Barak became Head of European Pricing, managing the regional function and developing international pricing strategies for four of the seven GlaxoWellcome therapy areas, including European pricing strategies for CNS, cardiovascular, oncology, anesthesiology and diabetes drugs. In 2001, Mr. Barak joined Oxford GlycoSciences as International Pricing and Reimbursement Manager, developing global pricing, reimbursement, and market access strategy for Zavesca, the company's first pharmaceutical launch. In 2002, Mr. Barak established his own consultancy, ABPPC Ltd, and formed a global network of consultants that provide the international pharmaceutical and health care community with specialized support for pricing, reimbursement, and market access. The network covers 22 countries, and is represented by Boston Healthcare in the UK and US.
About Boston Healthcare
Boston Healthcare assists emerging and established biopharmaceutical,
medical device and diagnostic companies in gaining a competitive advantage
in the health care marketplace by helping them unlock the value of
innovative drugs, devices, and diagnostics. These companies rely on Boston
Healthcare to create opportunities, navigate complexity, grow their
businesses, and achieve objectives through reimbursement, business
development, and market strategies. Clients draw on Boston Healthcare's
unique approach to gain a real-world edge in a highly competitive health
|SOURCE Boston Healthcare Associates, Inc.|
Copyright©2008 PR Newswire.
All rights reserved